Toronto Sun (02.23.10) - Thursday, February 25, 2010
Health Canada now has approved the human papillomavirus
vaccine Gardasil for use in males ages nine through 26.
Gardasil targets four HPV strains that are responsible for
most cases of genital warts and cervical cancer.
The vaccine was approved for use in females of this age range
in Canada in 2007, and since then provinces across the nation
have been inoculating girls in school-based clinics. Health
Canada said an ongoing review of data could result in the
school programs offering the vaccine to boys as well.
Data on the success of the effort in Canada are limited. In
Australia, however, where an estimated 70 percent of women
under age 28 have been vaccinated, research has documented a
reduction in the incidence of genital warts.
"Since 2008, there has been a substantial and significant
decline in genital warts in women 28 years of age and
younger," according to the study.